HLA in Narcolepsy
暂无分享,去创建一个
[1] G. Mueller‐Eckhardt,et al. HLA and narcolepsy in a German population. , 2008, Tissue antigens.
[2] J. Dausset,et al. HLA and multiple sclerosis: population and families study. , 2008, Tissue antigens.
[3] G. Thomson. The mode of inheritance of the HLA-linked gene predisposing to narcolepsy. , 2008, Tissue antigens.
[4] M. Billiard,et al. Possible association between HLA-B7 and narcolepsy. , 2008, Tissue antigens.
[5] G. Stewart,et al. Strong linkage disequilibrium between HLA-Dw2 and and BfS in multiple sclerosis and in the normal population. , 2008, Tissue antigens.
[6] H. Mcdevitt,et al. HLA-D antigens in the Japanese population. , 2008, Tissue antigens.
[7] J. Montplaisir,et al. Narcolepsy in monozygotic twins , 1987, Neurology.
[8] Eric O Long,et al. Mapping of the class II region of the human major histocompatibility complex by pulsed-field gel electrophoresis , 1986, Nature.
[9] K. Šonka,et al. DR2–NEGATIVE NARCOLEPSY , 1986, The Lancet.
[10] W. Ollier,et al. HLA-Dw specificity assignments are independent of HLA-DQ, HLA-DR, and other class II specificities and define a biologically important segregant series which strongly activates a functionally distinct T cell subset. , 1986, Human immunology.
[11] J. Ilonen,et al. Immune functions in healthy blood donors with HLA-DW2 and -DW3 antigens. , 1986, Immunobiology.
[12] D. Vergani,et al. Immune factors in narcolepsy. , 1986, Sleep.
[13] H. Inoko,et al. HLA-DR2 and Dw2 in narcolepsy and in other disorders of excessive somnolence without cataplexy. , 1986, Sleep.
[14] F. Bach,et al. DNA restriction fragment length polymorphisms characteristic for Dw subtypes of DR2. , 1986, Human immunology.
[15] M. Baur,et al. Homogeneity of HLA-DQ,DR phenotypes in lymphocyte subsets of normal individuals. , 1986, Human immunology.
[16] R. Godbout,et al. Nocturnal sleep of narcoleptic patients: revisited. , 1986, Sleep.
[17] W. Dement,et al. Muscarinic cholinergic receptors and the canine model of narcolepsy. , 1986, Sleep.
[18] C. Ninomiya,et al. Increased frequency of non-insulin-dependent diabetes mellitus among narcoleptic patients. , 1986, Sleep.
[19] A. Besset,et al. HLA-DR2 and narcolepsy. , 1986, Sleep.
[20] J. Parkes,et al. Narcolepsy and immunity. , 1986, British medical journal.
[21] R. Godbout,et al. The effect of zimelidine, a serotonin-reuptake blocker, on cataplexy and daytime sleepiness of narcoleptic patients. , 1986, Clinical neuropharmacology.
[22] M. Satake,et al. Human histocompatibility leukocyte antigen (HLA) haplotype frequencies estimated from the data on HLA class I, II, and III antigens in 111 Japanese narcoleptics. , 1985, The Journal of clinical investigation.
[23] S. Schleifer,et al. Stress and immunomodulation: the role of depression and neuroendocrine function. , 1985, Journal of immunology.
[24] J. M. Boss,et al. Genetic Complexity and Expression of Human Class II Histocompatibility Antigens , 1985, Immunological reviews.
[25] R. Spielman,et al. Structure, Sequence and Polymorphism in the HLA‐D Region , 1985, Immunological reviews.
[26] C. Auffray,et al. Gene organization of DC and DX subregions of the human major histocompatibility complex. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[27] M. Baur,et al. Histocompatibility Testing 1984 , 1985, Springer Berlin Heidelberg.
[28] M. Satake,et al. EXTRAORDINARY ASSOCIATION BETWEEN HLA-DR2 AND NARCOLEPSY , 1985, The Lancet.
[29] J. Dausset,et al. Clusters of HLA class II beta restriction fragments describe allelic series. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[30] R. Vaughan,et al. GENETIC MARKERS IN NARCOLEPSY , 1984, The Lancet.
[31] M. Satake,et al. HLA antigens in Japanese patients with narcolepsy , 1984 .
[32] C. Brautbar,et al. Definition of a new DR2 short associated HLA-D specificity with the Ninth Histocompatibility Workshop reagents. , 1984, Tissue antigens.
[33] L. Strong,et al. Human C4 haplotypes with duplicated C4A or C4B. , 1984, American journal of human genetics.
[34] E. Yunis,et al. An unusual "morphologic" variant of BF S. , 1984, American journal of human genetics.
[35] Charles Auffray,et al. The class II molecules of the human and murine major histocompatibility complex , 1984, Cell.
[36] D. Larhammar,et al. Exon-intron organization and complete nucleotide sequence of a human major histocompatibility antigen DC beta gene. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[37] H. Cann,et al. Analysis of HLA class I genes with restriction endonuclease fragments: implications for polymorphism of the human major histocompatibility complex. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[38] P. A. Peterson,et al. Detection of HLA-D/DR-related DNA polymorphism in HLA-D homozygous typing cells. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[39] J. Bodmer,et al. Sequences related to HLA-DR alpha chain on human chromosome 6: restriction enzyme polymorphism detected with DC alpha chain probes. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[40] J. Kaufman,et al. The extracellular region of light chains from human and murine MHC class II antigens consists of two domains. , 1983, Journal of immunology.
[41] D. Larhammar,et al. Complete amino acid sequence of an HLA-DR antigen-like beta chain as predicted from the nucleotide sequence: similarities with immunoglobulins and HLA-A, -B, and -C antigens. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[42] D. Meyers,et al. HLA-Dw2: a genetic marker for human immune response to short ragweed pollen allergen Ra5. I. Response resulting primarily from natural antigenic exposure , 1982, The Journal of experimental medicine.
[43] J. McNally,et al. EVIDENCE FOR A LONG PREDIABETIC PERIOD IN TYPE I (INSULIN-DEPENDENT) DIABETES MELLITUS , 1981, The Lancet.
[44] E. Poole. Diagnostic classification of sleep and arousal disorders—sleep Vol. 2, no. 1. 137 pp. Raven Press, New York (1979) $15.00 , 1981, Neuroscience.
[45] B. Benacerraf. Role of MHC gene products in immune regulation. , 1981, Science.
[46] C. Rittner,et al. On the significance of C2, C4, and factor B polymorphisms in disease , 1981, Human Genetics.
[47] G. Hauptmann,et al. A hemolytically inactive gene product of factor B. , 1980, Immunobiology.
[48] A. Vincent,et al. Clinical, pathological, HLA antigen and immunological evidence for disease heterogeneity in myasthenia gravis. , 1980, Brain : a journal of neurology.
[49] P. Thomas,et al. Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[50] J. Seignalet. Recherche d'anticorps anti-cellules B et typages HLA-DR à Montpellier , 1980 .
[51] M. Mamelak,et al. Narcolepsy: a family study. , 1979, Biological psychiatry.
[52] J. Parkes,et al. Genetic study of narcoleptic syndrome. , 1978, Journal of medical genetics.
[53] G. Hauptmann,et al. The nomenclature of properdin factor B allotypes. , 1978, Zeitschrift fur Immunitatsforschung. Immunobiology.
[54] P. Terasaki,et al. Microdroplet testing for HLA-A, -B, -C, and -D antigens. The Phillip Levine Award Lecture. , 1978, American journal of clinical pathology.
[55] J. Atkinson,et al. Mapping of the HLA locus controlling C2 structural variants and linkage disequilibrium between alleles C22 and Bw15 , 1976 .
[56] I. Peart,et al. Unilateral cataplexy associated with systemic lupus erythematosus , 1976, Journal of neurology, neurosurgery, and psychiatry.
[57] E. Southern. Detection of specific sequences among DNA fragments separated by gel electrophoresis. , 1975, Journal of molecular biology.
[58] C. Guilleminault,et al. A FAMILY STUDY OF 50 REM NARCOLEPTICS , 1974, Acta neurologica Scandinavica.
[59] E. Albert,et al. Population genetics of the MLC response: typing for MLC determinants using homozygous and heterozygous reference cells. , 1973, Transplantation proceedings.
[60] D. B. Amos,et al. Three closely linked genetic systems relevant to transplantation. , 1971, Proceedings of the National Academy of Sciences of the United States of America.
[61] D. B. Amos,et al. PHENOTYPIC EXPRESSIONS OF THE MAJOR HISTOCOMPATIBILITY LOCUS IN MAN (HL-A): LEUKOCYTE ANTIGENS AND MIXED LEUKOCYTE CULTURE REACTIVITY , 1968, The Journal of experimental medicine.
[62] L. Old,et al. GENETIC BASIS OF SUSCEPTIBILITY TO VIRAL LEUKAEMOGENESIS. , 1964, Lancet.
[63] W. Donnelly,et al. Differences between lymphocytes of leukemic and non-leukemic patients with respect to morphologic features, motility, and sensitivity to guinea pig serum. , 1961, Blood.
[64] N. Imlah. NARCOLEPSY IN IDENTICAL TWINS , 1961, Journal of neurology, neurosurgery, and psychiatry.
[65] E. Cambau. HLA et maladies , 1988 .
[66] J. Montplaisir,et al. HLA antigens in narcolepsy and idiopathic central nervous system hypersomnolence. , 1986, Sleep.
[67] J. Dausset,et al. Association of class II HLA-DQ beta chain DNA restriction fragments with multiple sclerosis. , 1985, Immunogenetics.
[68] W. Ollier,et al. HLA-D and DR in Different Populations , 1984 .
[69] L. Degos,et al. HLA-DR, DQ, and Dw Relationships , 1984 .
[70] R. Porter. Complement polymorphism, the major histocompatibility complex and associated diseases: a speculation. , 1983, Molecular biology & medicine.
[71] B. Roth,et al. Heredofamilial aspects of narcolepsy and hypersomnia. , 1972, Schweizer Archiv fur Neurologie, Neurochirurgie und Psychiatrie = Archives suisses de neurologie, neurochirurgie et de psychiatrie.
[72] D. Daly,et al. A family with narcolepsy. , 1959, Proceedings of the staff meetings. Mayo Clinic.